Summary
A suspension of heat-killed Aspergillus fumigatus mycelium inhibited the growth of a chemically-induced mouse bladder tumor (MBT). Tumor growth was inhibited when the mycelium was injected into mice in a mixture with the tumor cells, when injected into growing tumors, and when introduced IP at the time tumor cells were injected into the hind leg muscle. In the concentrations that affected tumor growth no toxicity of the fungus preparation was observed. The fungal suspension was more effective against MBT than a Corynebacterium parvum strain known to be a potent biologic response modifier. A significant increase in the number of mouse peritoneal exudate cells (PEC) was noted following inoculation with the mycelium. The induced PEC were cytotoxic to the tumor cells in vivo, suggesting that at least part of the tumor inhibition by the mycelium is host-mediated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Basic I, Milas L, Grdina DJ, Withers HR (1974) Destruction of hamster ovarian cell cultures by peritoneal macrophages from mice treated with Corynebacterium granulosum. J Natl Cancer Inst 52:1839
Basic I, Milas L, Grdina DJ, Withers HR (1975) In vitro destruction of tumor cells by macrophages from mice treated with Corynebacterium granulosum. J Natl Cancer Inst 55:589
Cassone A, Marconi P, Bistoni F, Mattia E, Sbaraglia G, Garaci E, Bonmassar E (1981) Immunoadjuvant effects of Candida albicans and its cell wall fractions in a mouse lymphoma model. Cancer Immunol Immunother 10:181
Chirigos MA (1978) Glucan. In: Chirigos MA (ed) Immune modulation and control of neoplasia by adjuvant therapy. Raven Press, New York, pp 171–280
Cochran AJ (1978) Immunotherapy. In: Man, cancer and immunity. Academic Press, London New York San Francisco, p 160
Cook JA, Taylor D, Cohen C, Rodrigue J, Malshet V, Di Luzio NR (1978) Comparative evaluation of the role of macrophages and lymphocytes in mediating the antitumor action of glucan. Prog Cancer Res Ther 7:183
Currie G (1980) Non-specific active immunotherapy. In: Cancer and the immune response. Year Book Medical Publishers, Chicago, p 97
deKernion J, Ramming K, Fraser K (1977) Immunotherapy and chemoimmunotherapy of FANFT bladder tumor. AACR Abstracts 462
deKernion JB, Ramming KP, Fraser K (1978) A bladder-tumor model response to immunotherapy. Natl Cancer Inst Monogr 49:333
Di Luzio NR, Williams DL, McNamee RB, Edwards BF, Kitahama A (1979) Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int J Cancer 24:773
Foster RS Jr (1979) Granulocyte and macrophage proliferation after injection of antitumor active and inactive strains of Corynebacterium parvum. Cancer Immunol Immunother 5:235
Gabizon A, Lelbovich SJ, Goldman R (1980) Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo. J Natl Cancer Inst 65:913
Israel L (1975) Report of 414 cases of human tumors treated with Corynebacteria. In: Halpern B (ed) Corybacterium parvum. Applications in experimental and clinical oncology. Plenum Press, New York, p 389
Israel L, Edelstein R, Depierre A, Dimitrov N (1975) Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: A preliminary report of clinical and biologic findings. (Brief communication) J Natl Cancer Inst 55:29
Kawase I, Uemiya M, Yoshimoto T, Ogura T, Hirao F, Yamamura Y (1981) Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma. Cancer Res 41:660
Keller R (1977) Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents. (Brief communication) J Natl Cancer Inst 59:1751
Mankowski ZT, Diller IC, Fisher ME (1957) The effect of various fungi on mouse tumors with special reference to sarcoma 37. Cancer Res 17:382
Matsumoto T, Takanohashi M, Okubo Y, Suzuku M, Suzuki S (1980) Growth inhibitory activity of the d-mannan of Saccharomyces cerevisiae X2180–1A-5 mutant strain against mouse-implanted sarcoma 180 and Ehrlich-carcinoma solid tumor. Carbohydr Res 83:363
Reilly HC (1953) Microbiology and cancer therapy: A review. Cancer Res 13:821
Reilly HC, Stock CC (1951) Studies on a tumor-retarding agent produced by Aspergillus fumigatus. Cancer Res 11:366
Riveros-Moreno V, Ford A (1980) Effect of periodate treatment and phenol extraction of C. parvum on its capacity to activate macrophages. Cancer Immunol Immunother 9:121
Saltarelli CG, Coppola CP (1980) Inhibitory effects of Candida albicans extracellular polysaccharides on mouse sarcoma 180. J Surg Oncol 15:99
Sone S, Pollack VA, Fidler IJ (1980) Direct activation of tumoricidal properties in rat alveolar macrophages by Nocardia rubra cell wall skeleton. Cancer Immunol Immunother 9:227
Sutemi O, Kumano N, Kurita K (1972) Antitumor activity of the yeast mannan preparation in relation to the effect of chemical modification. Gan 63:365
Suzuki M, Matsumoto T, Mikami T, Suzuki S (1976) Enhancing effect of a modified yeast mannan on the antitumor activity of mytomycin C. Gan 67:607
Weinberg JB, Hibbs JB (1979) Enhanced macrophage tumoricidal activity and tumor suppression or regression caused by heat-killed Candida albicans. J Natl Cancer Inst 63:1273
Whistler RL, Bushway AA, Singh PP (1976) Noncytotoxic antitumor polysaccharides. Adv Carbohydr Chem Biochem 32:235
Willmott N, Pimm MV, Baldwin RW (1979) Quantitative comparison of three C. parvum strains for immunotherapy of transplanted rat tumours. Cancer Immunol Immunother 7:117
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
deKernion, J.B., Lovrekovich, L. Antitumor effect of heat-killed Aspergillus fumigatus mycelium in a mouse model. Cancer Immunol Immunother 13, 145–148 (1982). https://doi.org/10.1007/BF00205316
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00205316